These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38165530)

  • 21. Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation.
    Zhang T; Zhou S; Hu L; Peng B; Liu Y; Luo X; Song Y; Liu X; Deng Y
    Int J Pharm; 2016 Dec; 515(1-2):449-459. PubMed ID: 27789365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner.
    Erikson E; Wratil PR; Frank M; Ambiel I; Pahnke K; Pino M; Azadi P; Izquierdo-Useros N; Martinez-Picado J; Meier C; Schnaar RL; Crocker PR; Reutter W; Keppler OT
    J Biol Chem; 2015 Nov; 290(45):27345-27359. PubMed ID: 26370074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the antitumor effects of vitamin K
    Shi J; Zhou S; Kang L; Ling H; Chen J; Duan L; Song Y; Deng Y
    Drug Deliv Transl Res; 2018 Feb; 8(1):1-11. PubMed ID: 28849577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib.
    Korani M; Nikoofal-Sahlabadi S; Nikpoor AR; Ghaffari S; Attar H; Mashreghi M; Jaafari MR
    Anticancer Agents Med Chem; 2020; 20(6):700-708. PubMed ID: 31893998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialic Acid Conjugate-Modified Cationic Liposomal Paclitaxel for Targeted Therapy of Lung Metastasis in Breast Cancer: What a Difference the Cation Content Makes.
    Sun W; Han C; Ge R; Jiang X; Wang Y; Han Y; Wang N; Song Y; Yang M; Chen G; Deng Y
    Mol Pharm; 2024 Apr; 21(4):1625-1638. PubMed ID: 38403951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity.
    Sui D; Tang X; Ding J; Wang Y; Qin Y; Zhang N; Liu X; Deng Y; Song Y
    Int J Pharm; 2021 Jun; 602():120552. PubMed ID: 33798685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy.
    Tang X; Sui D; Liu M; Zhang H; Liu M; Wang S; Zhao D; Sun W; Liu M; Luo X; Lai X; Liu X; Deng Y; Song Y
    Int J Pharm; 2020 Nov; 590():119929. PubMed ID: 33010395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposomal Doxorubicin: the Sphingomyelin/Cholesterol System Significantly Enhances the Antitumor Efficacy of Doxorubicin.
    Meng X; Zhang H; Chen L; Wang M; Zhang K; Liu X; Deng Y; Song Y
    AAPS PharmSciTech; 2023 Feb; 24(2):64. PubMed ID: 36759405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialic acid conjugate-modified liposomal platform modulates immunosuppressive tumor microenvironment in multiple ways for improved immune checkpoint blockade therapy.
    Li C; Qiu Q; Gao X; Yan X; Fan C; Luo X; Liu X; Wang S; Lai X; Song Y; Deng Y
    J Control Release; 2021 Sep; 337():393-406. PubMed ID: 34171446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals.
    Wu Y; Yang Y; Zhang FC; Wu C; Lü WL; Mei XG
    J Liposome Res; 2011 Sep; 21(3):221-8. PubMed ID: 20929434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sialic Acid-Modified O-GlcNAc Transferase Inhibitor Liposome Presents Antitumor Effect in Hepatocellular Carcinoma.
    Lin B; Chai S; Zhang Q; Lu Y; Hu J; Zhang J; Du YZ; Wu L
    Mol Pharm; 2024 Jan; 21(1):102-112. PubMed ID: 37994899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted Delivery of Arctigenin Using Sialic Acid Conjugate-Modified Liposomes for the Treatment of Breast Cancer.
    Liu S; He Y; Feng M; Huang Y; Wu W; Wang J
    Molecules; 2024 Jan; 29(1):. PubMed ID: 38202860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
    Cai L; Wang X; Wang W; Qiu N; Wen J; Duan X; Li X; Chen X; Yang L; Qian Z; Wei Y; Chen L
    Int J Nanomedicine; 2012; 7():4499-510. PubMed ID: 22923988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nano-chemotherapy using cationic liposome that strategically targets the cell membrane potential of pancreatic cancer cells with negative charge.
    Motomura M; Ichihara H; Matsumoto Y
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1161-1165. PubMed ID: 29534927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.
    Mori A; Kennel SJ; van Borssum Waalkes M; Scherphof GL; Huang L
    Cancer Chemother Pharmacol; 1995; 35(6):447-56. PubMed ID: 7882453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sialic Acid-Functionalized pH-Triggered Micelles for Enhanced Tumor Tissue Accumulation and Active Cellular Internalization of Orthotopic Hepatocarcinoma.
    Xu XL; Lu KJ; Zhu ML; Du YL; Zhu YF; Zhang NN; Wang XJ; Kang XQ; Xu DM; Ying XY; Yu RS; Lu CY; Ji JS; You J; Du YZ
    ACS Appl Mater Interfaces; 2018 Sep; 10(38):31903-31914. PubMed ID: 30178997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization design of sialic acid derivatives enhances the performance of liposomes for modulating immunosuppressive tumor microenvironments.
    Sui D; Liang K; Gui Y; Du Z; Xin D; Yu G; Zhai W; Liu X; Song Y; Deng Y
    Life Sci; 2022 Dec; 310():121081. PubMed ID: 36273630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R; Zhong T; Zhang WQ; Song P; Song WD; Zhao Y; Wang C; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2014; 9():3091-105. PubMed ID: 25028548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
    Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of Dose on Neutrophil-Mediated Delivery of Nanoparticles for Tumor-Targeting Therapy Strategies.
    Liu M; Li C; NaYan ; Zhao D; Zhang H; Li J; Tang X; Liu X; Deng Y; Song Y
    AAPS PharmSciTech; 2021 Mar; 22(3):89. PubMed ID: 33665749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.